Do all adults with growth hormone deficiency require growth hormone treatment?

Annals of Medicine

Volumn 35, Issue 6, 2003, Pages 419-424

  Brooke, Antonia M ^a   Monson, John P ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

GH deficiency; GH replacement; Hypopituitarism; Quality of life

Indexed keywords

GROWTH HORMONE;

ANXIETY DISORDER; BODY COMPOSITION; BONE DENSITY; BONE MINERAL; CARDIOVASCULAR RISK; DEPRESSION; DRUG EFFECT; EXTRACELLULAR SPACE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS DISEASE; HYPOPITUITARISM; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LEAN BODY WEIGHT; MENTAL DISEASE; MOOD DISORDER; MORTALITY; OBESITY; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SOCIAL ISOLATION; WELLBEING;

ADULT; BODY COMPOSITION; BODY HEIGHT; BONE DENSITY; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; PATIENT SELECTION; QUALITY OF LIFE;

EID: 0142095008     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/07853890310001320     Document Type: Review

References (32)

1. Lamberts SW, Valk NK, Binnerts A. The use of Growth Hormone in adults: a changing scene. Clin Endocrinol 1992; 37: 111-5.
2. Littley MD, Shalet SM, Swindell R, Beardwell CG, Sutton ML. Low-dose pituitary irradiation for acromegaly. Clin Endocrinol 1990; 32: 261-70.
3. Abs R, Bengtsson BA, Hernberg-Stahl E, Monson JP, Tauber JP, Wilton P, et al. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clin Endocrinol 1999; 50: 703-13.
4. de Boer H, Blok GJ, van der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995; 16: 63-86.
5. Carroll PV, Christ ER, Bengttson BA, Carlsson L, Christiansen JS, Clemmons D, et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 1998; 83: 382-95.
6. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 2001; 357: 425-31.
7. Bulow B, Hagmar L, Mikoczy Z, Nordstrom CH, Erfurth EM. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol 1997; 46: 75-81.
8. Toogood AA, Beardwell CG, Shalet SM. The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clin Endocrinol 1994; 41: 511-6.
9. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 1998; 83: 379-81.
10. Hoffman DM, Nguyen TV, O'Sullivan AJ, Baxter RC, Ho KK. Diagnosis of growth hormone deficiency in adults. Lancet 1994; 344: 482-3.
11. Rahim A, Toogood AA, Shalet SM. The assessment of growth hormone status in normal young adult males using a variety of provocative agents. Clin Endocrinol 1996; 45: 557-62.
12. Drake WM, Coyte D, Camacho-Hubner C, Jivanji NM, Kaltsas G, Wood DF, et al. Optimising growth hormone replacement therapy by dose titration in hypopituitary adults. J Clin Endocrinol Metab. 1998; 83: 3913-9.
13. Jorgensen JO, Pedersen SA, Thuesen L, Jorgensen J, Ingemann-Hansen T, Shakkebaek NE, et al. Beneficial effects of growth hormone treatment in growth hormone-deficient adults. Lancet 1989; 1: 1221-5.
14. Burman P, Broman JE, Hetta J, Wiklund I, Erfurth EM, Hagg E, et al. Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. J Clin Endocrinol Metab 1995; 80: 3585-90.
15. Sanmarti A, Lucas A, Hawkins F, Webb SM, Ulied A. Observational study in adult hypopituitary patients with untreated growth hormone deficiency (ODA study). Socioeconomic impact and health status. Collaborative ODA (observation growth hormone deficiency in adults group). Eur J Endocrinol 1999; 141: 481-9.
16. McKenna SP, Doward LC, Alonso J. The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Qual Life Res 1999; 8: 373-83.
17. Whitehead HM, Boreham C, McIlrath EM, Sheridan B, Kennedy L, Atkinson AB, et al. Growth hormone treatment of adults with growth hormone deficiency - results of a 13-month placebo controlled cross-over study. Clin Endocrinol 1992; 36: 45-52.
18. Bengtsson BA, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G, et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993; 76: 309-17.
19. Hernberg-Stahl E, Luger A, Abs R, Bengtsson BA, Fledt-Rasmussen U, Wilton P, et al. Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency. J Clin Endocrinol Metab 2001; 86: 5277-81.
20. Salomon F, Cuneo RC, Hesp R, Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Eng J Med 1989; 321: 1797-803.
21. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson BA. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 1997; 137: 240-5.
22. Weaver JU, Monson JP, Noonan K, Price C, Edwards A, Evans KA, et al. The effects of low dose recombinant human growth hormone replacement on indices of bone remodelling and bone mineral density in hypopituitary growth hormone deficient adults. Endocrinol Metab 2003; 1996: 55-61.
23. Drake WM, Rodriguez-Arnao J, Weaver JU, James I, Coyte D, Spector T, et al. The influence of gender on the short and long term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults - a five year study. Clin Endocrinol 2001; 54: 525-32.
24. Weaver JU, Monson JP, Noonan K, John WG, Edwards A, Evans KA, et al. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metab 1995; 80: 153-9.
25. Caidahl K, Eden S, Bengtsson BA. Cardiovascular and renal effects of growth hormone. Clin Endocrinol 1994; 40: 393-400.
26. Nass R, Huber RM, Klauss V, Muller OA, Schopohl J, Strasburger CJ. Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. J Clin Endocrinol Metab 1995; 80: 552-7.
27. Woodhouse LJ, Asa SL, Thomas SG, Ezzat S. Measures of submaximal aerobic performance evaluate and predict functional response to growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab 1999; 84: 4570-7.
28. Gibney J, Wallace JD, Spinks T, Schnorr L, Ranicar A, Cuneo RC, et al. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients. J Clin Endocrinol Metabol 1999; 84: 2596-602.
29. Holmes SJ, Shalet SM. Which adults develop side-effects of growth hormone replacement? Clin Endocrinol 1995; 43: 143-9.
30. Frajese V, Drake W, Loureiro RA, Evanson J, Coyte D, Wood DF, et al. Hypothalamo-pituitary imaging in hypopituitary patients treated with growth hormone. J Clin Endocrinol Metab 2001; 86: 5172-5.
31. Swerdlow AJ, Higgins CD, Adlard P, Preece MA. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet 2002; 360: 273-7.
32. Monson JP, Abs R, Bengtsson B-Å, Bennmarker H, Feldt-Rasmussen U, Hernberg-Ståhl E, et al. Growth hormone deficiency and replacement in elderly hypopituitary adults. Clin Endocrinol 2000; 53: 281-9.